Literature DB >> 21244639

Synthesis and biological evaluation of new quinoxaline derivatives as antioxidant and anti-inflammatory agents.

Asunción Burguete1, Eleni Pontiki, Dimitra Hadjipavlou-Litina, Saioa Ancizu, Raquel Villar, Beatriz Solano, Elsa Moreno, Enrique Torres, Silvia Pérez, Ignacio Aldana, Antonio Monge.   

Abstract

We report the synthesis, anti-inflammatory, and antioxidant activities of novel quinoxaline and quinoxaline 1,4-di-N-oxide derivatives. Microwave-assisted methods have been used to optimize reaction times and to improve yields. The tested compounds presented important scavenging activities and promising in vitro inhibition of soybean lipoxygenase (LOX). Two of the best LOX inhibitors (compounds 7b and 8f) were evaluated as in vivo anti-inflammatory agents using the carrageenin-induced edema model. One of them (compound 7b) showed important in vivo anti-inflammatory effect (41%) similar to that of indomethacin (47%) used as the reference drug.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244639     DOI: 10.1111/j.1747-0285.2011.01076.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  11 in total

1.  Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.

Authors:  Mery Santivañez-Veliz; Silvia Pérez-Silanes; Enrique Torres; Elsa Moreno-Viguri
Journal:  Bioorg Med Chem Lett       Date:  2016-03-18       Impact factor: 2.823

2.  In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis.

Authors:  Vanessa Kaplum; Juliana Cogo; Diego Pereira Sangi; Tânia Ueda-Nakamura; Arlene Gonçalves Corrêa; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

3.  Sensing study of quinoxaline analogues with theoretical calculation, single-crystal X-ray structure and real application in commercial fruit juices.

Authors:  Shampa Chakraborty; Shyamaprosad Goswami; Ching Kheng Quah; Bholanath Pakhira
Journal:  R Soc Open Sci       Date:  2018-06-06       Impact factor: 2.963

4.  Fused-ring derivatives of quinoxalines: spectroscopic characterization and photoinduced processes investigated by EPR spin trapping technique.

Authors:  Zuzana Barbieriková; Dana Dvoranová; Maroš Bella; Viktor Milata; Adriana Czímerová; Vlasta Brezová
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

5.  New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Authors:  Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

6.  Construction of a novel quinoxaline as a new class of Nrf2 activator.

Authors:  Murugesh Kandasamy; Kit-Kay Mak; Thangaraj Devadoss; Punniyakoti Veeraveedu Thanikachalam; Raghavendra Sakirolla; Hira Choudhury; Mallikarjuna Rao Pichika
Journal:  BMC Chem       Date:  2019-09-24

Review 7.  Recent advances in the transition-metal-free synthesis of quinoxalines.

Authors:  Biplob Borah; L Raju Chowhan
Journal:  RSC Adv       Date:  2021-11-19       Impact factor: 4.036

Review 8.  Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.

Authors:  Guyue Cheng; Wei Sa; Chen Cao; Liangliang Guo; Haihong Hao; Zhenli Liu; Xu Wang; Zonghui Yuan
Journal:  Front Pharmacol       Date:  2016-03-21       Impact factor: 5.810

9.  Voltammetric Study of Some 3-Aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide Derivatives with Anti-Tumor Activities.

Authors:  Eric M Miller; Qing Xia; Mariah E Cella; Austin W Nenninger; Monica N Mruzik; Krystina A Brillos-Monia; Yong Zhou Hu; Rong Sheng; Christina M Ragain; Philip W Crawford
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

10.  New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities.

Authors:  Carlos Barea; Adriana Pabón; Silvia Pérez-Silanes; Silvia Galiano; German Gonzalez; Antonio Monge; Eric Deharo; Ignacio Aldana
Journal:  Molecules       Date:  2013-04-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.